111 completed, 52 recruiting, 38 unknown, 25 active not recruiting. 111 Not applicable, 30 Phase 2, 18 Phase 4, 15 Phase 3, 5 Phase 1.
Follow University Hospital, Akershus: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mental Health INtervention With Digital APPlications (MIND-APP): Randomized Controlled Researcher Blinded Trial Evaluating the Effectiveness of the Tankevirus and Grubl Mental Health Apps Tankevirus, Grubl, Placebo Application - Anxiety, Depression | Not applicable | Not yet recruiting | University Hospital, Akershus | 1000 | 2027-08-15 | 2026-06-04 |
| Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism Reduced-dose alteplase, Full-dose alteplase - Pulmonary Embolism Acute | Phase 4 | Not yet recruiting | Sahlgrenska University Hospital | 400 | 2026-12-01 | 2026-09-17 |
| The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease Urolithin A, Placebo Control - Alzheimer's Disease (AD), Early Alzheimer's Disease | Not applicable | Recruiting | University Hospital, Akershus | 60 | 2026-09-26 | 2026-10-08 |
| Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE Tociliuzumab, Placebo - Acute Ischemic Stroke | Phase 2 / Phase 3 | Not yet recruiting | Oslo University Hospital | 156 | 2026-09-21 | 2026-10-13 |
| More Realistic Spine Patients: Assessing the Effect of Dialogue Support Tool. Dialogue Support Study Visit - Spinal Stenosis Lumbar, Disc Herniation, Lumbar | Not applicable | Recruiting | University Hospital, Akershus | 440 | 2026-09-01 | 2026-10-05 |
| Ureteroscopic Lithotripsy for Renal Stones Using a Sheathless Approach or Using a Flexible and Navigable Ureteral Access Sheath (FANS) Sheathless URS, FANS, low power, FANS, high power - Renal Stones | Not applicable | Not yet recruiting | Haukeland University Hospital | 225 | 2026-08-15 | 2026-08-03 |
| Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer Active surveillance, Adjuvant chemoradiotherapy - Rectal Cancer | Not applicable | Recruiting | Medical University of Gdansk | 480 | 2026-06-14 | 2026-06-25 |
| Mechanisms of Persistent Fatigue Fatigue Post Viral | Recruiting | University Hospital, Akershus | 300 | 2026-04-28 | 2026-05-22 | |
| Aminoglycosides in Early Sepsis Gentamicin + narrow spectrum betalactam, Cefotaxime, Piperacillin-tazobactam - Sepsis | Phase 4 | Recruiting | University Hospital, Akershus | 1900 | 2026-04-23 | 2026-04-24 |
| Vexus Assessment and Natriuresis-guided Diuretic Therapy in Acute Heart Failure Natriuresis-guided escalation of loop diuretics - Venous Congestion, Heart Failure Acute | Not applicable | Not yet recruiting | University Hospital, Akershus | 270 | 2026-04-01 | 2026-04-30 |
| Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance Fecal occult blood testing, Colonoscopy - Colorectal Neoplasms | Not applicable | Recruiting | Sorlandet Hospital HF | 4000 | 2026-01-09 | 2026-01-15 |
| PERsonalized Mammographic Screening in Norway Breast Cancer, Mammographic Breast Density | Not yet recruiting | Norwegian Institute of Public Health | 3000 | 2026-01-01 | 2026-01-29 | |
| Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer µCAN drug screen test, Standard-of-Care Therapy - Metastatic Colorectal Cancer (mCRC) | Not applicable | Recruiting | Oncosyne AS | 75 | 2025-10-28 | 2026-04-30 |
| BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache Cerebri-TTH biofeedback, headache diary - Tension Type Headache | Not applicable | Recruiting | Helse Nord-Trøndelag HF | 300 | 2025-10-17 | 2026-07-21 |
| Akershus Cardiac Examination (ACE) 5 Study Lung Cancer Screening Plus Program, Standard of Care - Heavy Smokers, Lung Cancer Screening | Not applicable | Recruiting | University Hospital, Akershus | 1000 | 2025-10-01 | 2025-12-24 |
| Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly Norwegian SMS, Polish/Ukrainian SMS - Influenza | Not applicable | Unknown | Norwegian Institute of Public Health | 1000000 | 2025-10-01 | 2024-08-07 |
| The Holistic Study Avatrombopag, Rituximab (Arm B) - Thrombocytopenia Purpura | Phase 3 | Not yet recruiting | Ostfold Hospital Trust | 220 | 2025-09-15 | 2025-09-09 |
| Cardiomodulatory Effects of Gender-Affirming Hormone Therapy Gender Incongruence, Cardiovascular Disease (CVD) Risk Factors | Enrolling by invitation | University Hospital, Akershus | 450 | 2025-09-05 | 2026-01-12 | |
| Continuous Vital Sign Monitoring in a Surgical Ward Continuous Vital Sign Monitoring (CVSM) - Patient Monitoring, Wearable Devices | Recruiting | University Hospital, Akershus | 9600 | 2025-09-01 | 2026-07-09 | |
| Endoscopic Therapy Or Surgery for Early Colon Cancer eFTR, Surgery - Colon Cancer | Phase 3 | Recruiting | Norwegian Department of Health and Social Affairs | 434 | 2025-08-25 | 2025-11-20 |
Showing 20 of 255. Sign in to see all of them.
Heart Failure (9) · Colorectal Neoplasms (8) · COVID-19 (7) · Depression (7) · Ischemic Stroke (7) · Stroke (7) · Atherosclerosis (6) · Breast Neoplasms (6) · Cardiovascular Diseases (6) · Inflammation (6) · Anxiety Disorders (5) · Cognitive Dysfunction (5) · Mental Disorders (5) · Migraine Disorders (5) · Atrial Fibrillation (4)
Standard of Care (5) · Surgical Procedures, Operative (5) · nicotinamide-beta-riboside (4) · Crisis Intervention (3) · Exercise (3) · Fracture Fixation, Internal (3) · Rehabilitation (3) · Rituximab (3) · Sodium Chloride (3) · Therapeutics (3) · Atorvastatin (2) · Biopsy (2) · Dexamethasone (2) · Docosahexaenoic Acids (2) · Fluorouracil (2)
Norway (233) · Sweden (12) · Denmark (6) · Poland (4) · Estonia (3) · Finland (3) · France (2) · Italy (2) · Netherlands (2) · Argentina (1) · Colombia (1) · Czechia (1) · Ethiopia (1) · Germany (1) · Greece (1)
Asbjorn Aaroen, Professor (3) · Christofer Lundqvist, MD, PhD (2) · Gunnar Einvik, PhD (2) · Linn H Steffensen, Associate Professor II (2) · Magnus N Lyngbakken, MD PhD (2) · Michael B Russell, Professor (2) · Olav Dalgard, MD PhD (2) · Reidar Pedersen, PhD (2) · Tom Oresland, M.D., Ph.D. (2) · Vegard B Wyller (2) · Vegard Dahl, PhD (2)
PMID 33913035, PMID 34400140, PMID 35727196, PMID 40881041, PMID 22883540, PMID 23043722, PMID 23060463, PMID 23207160, PMID 23485794, PMID 24028201, PMID 24201679, PMID 24646429, PMID 24661577, PMID 24928284, PMID 24983687, PMID 25100734, PMID 25112307, PMID 26145718, PMID 26441181, PMID 26467530, PMID 26516490, PMID 26563095, PMID 26629812, PMID 26645391, PMID 26661319, PMID 26691895, PMID 26868015, PMID 26922148, PMID 26956476, PMID 27121539, PMID 27321869, PMID 27422025, PMID 27696633, PMID 27900127, PMID 27914187, PMID 28001320, PMID 28127388, PMID 28137255, PMID 28324697, PMID 28348183, PMID 28369734, PMID 28489253, PMID 28631827, PMID 28738895, PMID 29049469, PMID 29095966, PMID 29118031, PMID 29118784, PMID 29132733, PMID 29351646
2017 (4), 2019 (3), 2015 (2), 2014 (1)